These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. Bozza PT; Payne JL; Goulet JL; Weller PF J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909 [TBL] [Abstract][Full Text] [Related]
4. Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene Therapy. Roos J; Peters M; Maucher IV; Kühn B; Fettel J; Hellmuth N; Brat C; Sommer B; Urbschat A; Piesche M; Vogel A; Proschak E; Blöcher R; Buscató E; Häfner AK; Matrone C; Werz O; Heidler J; Wittig I; Angioni C; Geisslinger G; Parnham MJ; Zacharowski K; Steinhilber D; Maier TJ Antioxid Redox Signal; 2018 May; 28(14):1265-1285. PubMed ID: 28699354 [TBL] [Abstract][Full Text] [Related]
5. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]